Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine for Pain Treatment and Recovery After Total Knee Arthroplasty
NCT07538570Phase 4Active, not recruiting
- Sponsor
- Vertex Pharmaceuticals
- Start
- Apr 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 4 trial of suzetrigine in pain, sponsored by Vertex Pharmaceuticals. Started Apr 2026; status: active, not recruiting.
02
Drugs
suzetrigine
03
Conditions
pain
Beyond the preview
Go deeper on NCT07538570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07538570.